BERNADETTE HERRERA: Open Payments
NPI 1508156084 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,200 in 176 payments from 39 companies in 2025. Trend: 2023 $117 · 2024 $196 · 2025 $5,200
Food & beverage: $5,173Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $354 |
| Alexion Pharmaceuticals, Inc. | 5 | $314 |
| UCB, Inc. | 17 | $309 |
| JAZZ PHARMACEUTICALS INC. | 7 | $284 |
| HARMONY BIOSCIENCES LLC | 8 | $268 |
| SK Life Science, Inc. | 3 | $257 |
| Neurocrine BioSciences, Inc. | 9 | $245 |
| Lilly USA, LLC | 6 | $238 |
| Neurelis, Inc. | 6 | $210 |
| Lundbeck LLC | 6 | $192 |
Products named: ULTOMIRIS, WAKIX, INGREZZA, EPIDIOLEX, KISUNLA, VALTOCO, Fintepla, KESIMPTA.
Industry payments across NM — which companies pay providers there.
